Premature senescence involving p53 and p16 is activated in response to constitutive MEK/MAPK mitogenic signaling.
暂无分享,去创建一个
S. Lowe | M. Serrano | L. Van Aelst | M. Barradas | J. Stone | L. Aelst | Athena W. Lin | A. Lin
[1] D. Woods,et al. Senescence of human fibroblasts induced by oncogenic Raf. , 1998, Genes & development.
[2] M. Serrano,et al. p19ARF links the tumour suppressor p53 to Ras , 1998, Nature.
[3] J L Cleveland,et al. Myc signaling via the ARF tumor suppressor regulates p53-dependent apoptosis and immortalization. , 1998, Genes & development.
[4] S. Lowe,et al. E1A signaling to p53 involves the p19(ARF) tumor suppressor. , 1998, Genes & development.
[5] C. Marshall,et al. Signals from Ras and Rho GTPases interact to regulate expression of p21Waf1/Cip1 , 1998, Nature.
[6] U. Rapp,et al. High-intensity Raf signals convert mitotic cell cycling into cellular growth. , 1998, Cancer research.
[7] C. Marshall,et al. Signal transduction: Taking the Rap , 1998, Nature.
[8] D. Wong,et al. Inactivation of p16 in Human Mammary Epithelial Cells by CpG Island Methylation , 1998, Molecular and Cellular Biology.
[9] G. Peters,et al. Inhibitors of cyclin-dependent kinases induce features of replicative senescence in early passage human diploid fibroblasts , 1998, Current Biology.
[10] C. Greider. Telomeres and senescence: The history, the experiment, the future , 1998, Current Biology.
[11] J Downward,et al. Ras signalling and apoptosis. , 1998, Current opinion in genetics & development.
[12] M. Haas,et al. Independent induction of senescence by p16INK4a and p21CIP1 in spontaneously immortalized human fibroblasts. , 1998, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.
[13] J. Massagué. TGF-beta signal transduction. , 1998, Annual review of biochemistry.
[14] S. Lowe,et al. A signaling to p 53 involves the p 19 ARF tumor suppressor , 1998 .
[15] Richard A. Ashmun,et al. Tumor Suppression at the Mouse INK4a Locus Mediated by the Alternative Reading Frame Product p19 ARF , 1997, Cell.
[16] D. Haber. Splicing into Senescence: The Curious Case of p16 and p19ARF , 1997, Cell.
[17] L. Chin,et al. Cooperative effects of INK4a and ras in melanoma susceptibility in vivo. , 1997, Genes & development.
[18] S. Lowe,et al. Selective induction of p53 and chemosensitivity in RB-deficient cells by E1A mutants unable to bind the RB-related proteins. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[19] L. Van Aelst,et al. Rho GTPases and signaling networks. , 1997, Genes & development.
[20] E. Lees,et al. Raf-induced proliferation or cell cycle arrest is determined by the level of Raf activity with arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.
[21] A Sewing,et al. High-intensity Raf signal causes cell cycle arrest mediated by p21Cip1 , 1997, Molecular and cellular biology.
[22] G. Peters,et al. Accumulation of p16INK4a in mouse fibroblasts as a function of replicative senescence and not of retinoblastoma gene status , 1997, Oncogene.
[23] M. Nistér,et al. Induction of senescence in human malignant glioma cells by p16INK4A , 1997, Oncogene.
[24] F. Zindy,et al. Expression of the p16INK4a tumor suppressor versus other INK4 family members during mouse development and aging , 1997, Oncogene.
[25] J. Stone,et al. Interaction of activated Ras with Raf-1 alone may be sufficient for transformation of rat2 cells , 1997, Molecular and cellular biology.
[26] P. Warne,et al. Role of Phosphoinositide 3-OH Kinase in Cell Transformation and Control of the Actin Cytoskeleton by Ras , 1997, Cell.
[27] G. Wahl,et al. p53 Mediates Permanent Arrest over Multiple Cell Cycles in Response to γ-Irradiation , 1997 .
[28] S. Lowe,et al. Oncogenic ras Provokes Premature Cell Senescence Associated with Accumulation of p53 and p16INK4a , 1997, Cell.
[29] R. Weinberg. The Cat and Mouse Games That Genes, Viruses, and Cells Play , 1997, Cell.
[30] F. McCormick,et al. Signal transduction from multiple Ras effectors. , 1997, Current opinion in genetics & development.
[31] K. Pumiglia,et al. Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[32] G. V. Vande Woude,et al. Synergy between the Mos/mitogen-activated protein kinase pathway and loss of p53 function in transformation and chromosome instability , 1997, Molecular and cellular biology.
[33] G. Wahl,et al. p53 mediates permanent arrest over multiple cell cycles in response to gamma-irradiation. , 1997, Cancer research.
[34] P. Warne,et al. R-Ras can activate the phosphoinositide 3-kinase but not the MAP kinase arm of the Ras effector pathways , 1997, Current Biology.
[35] G. Hannon,et al. Involvement of the cyclin-dependent kinase inhibitor p16 (INK4a) in replicative senescence of normal human fibroblasts. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[36] Jonathan A. Cooper,et al. TC21 causes transformation by Raf-independent signaling pathways , 1996, Molecular and cellular biology.
[37] B. Howard,et al. Human fibroblast commitment to a senescence-like state in response to histone deacetylase inhibitors is cell cycle dependent , 1996, Molecular and cellular biology.
[38] C. Reznikoff,et al. Elevated p16 at senescence and loss of p16 at immortalization in human papillomavirus 16 E6, but not E7, transformed human uroepithelial cells. , 1996, Cancer research.
[39] L. Chin,et al. Role of the INK4a Locus in Tumor Suppression and Cell Mortality , 1996, Cell.
[40] M. Wigler,et al. Stimulation of Membrane Ruffling and MAP Kinase Activation by Distinct Effectors of RAS , 1996, Science.
[41] T. Urano,et al. Ral‐GTPases mediate a distinct downstream signaling pathway from Ras that facilitates cellular transformation. , 1996, The EMBO journal.
[42] David E. Housman,et al. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours , 1996, Nature.
[43] A. Bielawska,et al. Role of Ceramide in Cellular Senescence (*) , 1995, The Journal of Biological Chemistry.
[44] F. Zindy,et al. Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest , 1995, Cell.
[45] Zhimin Lu,et al. Involvement of Ral GTPase in v-Src-induced phospholipase D activation , 1995, Nature.
[46] Philip R. Cohen,et al. PD 098059 Is a Specific Inhibitor of the Activation of Mitogen-activated Protein Kinase Kinase in Vitro and in Vivo(*) , 1995, The Journal of Biological Chemistry.
[47] A. Balmain,et al. Deletion and altered regulation of p16INK4a and p15INK4b in undifferentiated mouse skin tumors. , 1995, Cancer research.
[48] C. Der,et al. Activation of Rac1, RhoA, and mitogen-activated protein kinases is required for Ras transformation , 1995, Molecular and cellular biology.
[49] C Roskelley,et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[50] M. Serrano,et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma , 1995, Science.
[51] J. Stone,et al. RAS signalling is abnormal in a c-raf1 MEK1 double mutant , 1995, Molecular and cellular biology.
[52] P. Atadja,et al. Increased activity of p53 in senescing fibroblasts. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[53] A. Bridges,et al. A synthetic inhibitor of the mitogen-activated protein kinase cascade. , 1995, Proceedings of the National Academy of Sciences of the United States of America.
[54] J. Barrett,et al. Genetic analysis of cellular senescence. , 1995, Biochimica et biophysica acta.
[55] C. Slaughter,et al. ERK phosphorylation potentiates Elk‐1‐mediated ternary complex formation and transactivation. , 1995, The EMBO journal.
[56] M. Wigler,et al. Multiple ras functions can contribute to mammalian cell transformation , 1995, Cell.
[57] J. Bischoff,et al. Identification of the guanine nucleotide dissociation stimulator for Ral as a putative effector molecule of R-ras, H-ras, K-ras, and Rap. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[58] Michael J. Fry,et al. Phosphatidylinositol-3-OH kinase direct target of Ras , 1994, Nature.
[59] N. Ahn,et al. Transformation of mammalian cells by constitutively active MAP kinase kinase. , 1994, Science.
[60] T. Taniguchi,et al. Cellular commitment to oncogene-induced transformation or apoptosis is dependent on the transcription factor IRF-1 , 1994, Cell.
[61] C. Marshall,et al. Activation of MAP kinase kinase is necessary and sufficient for PC12 differentiation and for transformation of NIH 3T3 cells , 1994, Cell.
[62] J. R. Smith,et al. Cloning of senescent cell-derived inhibitors of DNA synthesis using an expression screen. , 1994, Experimental cell research.
[63] C. Marshall,et al. MAP kinase kinase kinase, MAP kinase kinase and MAP kinase. , 1994, Current opinion in genetics & development.
[64] R. Weinberg,et al. Tumor spectrum analysis in p53-mutant mice , 1994, Current Biology.
[65] L. Donehower,et al. Reduction of p53 gene dosage does not increase initiation or promotion but enhances malignant progression of chemically induced skin tumors , 1993, Cell.
[66] M. Wigler,et al. Complex formation between RAS and RAF and other protein kinases. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[67] Bruno Amati,et al. Oncogenic activity of the c-Myc protein requires dimerization with Max , 1993, Cell.
[68] M. Kastan. P53: a determinant of the cell cycle response to DNA damage. , 1993, Advances in experimental medicine and biology.
[69] Gerard I. Evan,et al. Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.
[70] L. Donehower,et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours , 1992, Nature.
[71] J. Blenis,et al. Nuclear localization and regulation of erk- and rsk-encoded protein kinases , 1992, Molecular and cellular biology.
[72] A. Balmain,et al. Loss of heterozygosity and mutational alterations of the p53 gene in skin tumours of interspecific hybrid mice. , 1991, Oncogene.
[73] B. Villeponteau,et al. Long-term growth of diploid human fibroblasts in low serum media , 1990, Experimental Gerontology.
[74] H. Ruley. Transforming collaborations between ras and nuclear oncogenes. , 1990, Cancer cells.
[75] H. Land,et al. Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line. , 1990, Nucleic acids research.
[76] B. Vogelstein,et al. A genetic model for colorectal tumorigenesis , 1990, Cell.
[77] R. Weinberg,et al. Oncogenes, antioncogenes, and the molecular bases of multistep carcinogenesis. , 1989, Cancer research.
[78] H. Ruley,et al. Rescue of cells from ras oncogene-induced growth arrest by a second, complementing, oncogene. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[79] R. Holliday. Strong effects of 5-azacytidine on the in vitro lifespan of human diploid fibroblasts. , 1986, Experimental cell research.
[80] J. R. Smith,et al. Mitogenic effects of the proto-oncogene and oncogene forms of c-H-ras DNA in human diploid fibroblasts , 1986, Molecular and cellular biology.
[81] P. Byrd,et al. Transformation of human embryo retinoblasts with simian virus 40, adenovirus and ras oncogenes. , 1986, Anticancer research.
[82] B. Franza,et al. In vitro establishment is not a sufficient prerequisite for transformation by activated ras oncogenes , 1986, Cell.
[83] L. Hayflick. THE LIMITED IN VITRO LIFETIME OF HUMAN DIPLOID CELL STRAINS. , 1965, Experimental cell research.